Page last updated: 2024-08-21

cyproterone acetate and Thrombosis

cyproterone acetate has been researched along with Thrombosis in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (10.00)	18.7374
1990's	2 (20.00)	18.2507
2000's	2 (20.00)	29.6817
2010's	5 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Asiimwe, A; Bezemer, ID; Herings, RMC; Penning-van Beest, FJA; Smits, E	1
Arie, S	1
Kant, AC; van Hunsel, FP; van Puijenbroek, EP	1
Rosendaal, FR	1
Kant, A; van Hunsel, F; van Puijenbroek, E	1
Akcay, A; Bavbek, N; Gumus, II; Karakurt, F; Kargili, A; Koca, C; Kosar, A; Ozbek, M; Selcoki, Y	1
Andersen, LF; Bladbjerg, EM; Jespersen, J; Skouby, SO	1
Beaumont, JL; Beaumont, V	1
Beaucaire, G; Beuscart, C; Brion, M; Leroy, O; Senneville, E; Tillie, I; Visticot, F	1
Abbate, R; Bruni, V; Bucciantini, S; Costanzo, G; Costanzo, M; Pinto, S; Rosati, D; Verni, A	1

Trials

1 trial(s) available for cyproterone acetate and Thrombosis

Article	Year
Effects of different progestin regimens in hormone replacement therapy on blood coagulation factor VII and tissue factor pathway inhibitor. Human reproduction (Oxford, England), 2002, Volume: 17, Issue:12 Topics: Cholesterol, LDL; Cyproterone Acetate; Estradiol; Estrogen Replacement Therapy; Factor VII; Female; Humans; Levonorgestrel; Lipoproteins; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Placebos; Postmenopause; Progestins; Risk Factors; Thrombosis; Time Factors; Uterus	2002

Article

Year

Effects of different progestin regimens in hormone replacement therapy on blood coagulation factor VII and tissue factor pathway inhibitor.

Human reproduction (Oxford, England), 2002, Volume: 17, Issue:12

Topics: Cholesterol, LDL; Cyproterone Acetate; Estradiol; Estrogen Replacement Therapy; Factor VII; Female; Humans; Levonorgestrel; Lipoproteins; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Placebos; Postmenopause; Progestins; Risk Factors; Thrombosis; Time Factors; Uterus

2002

Other Studies

9 other study(ies) available for cyproterone acetate and Thrombosis

Article	Year
Thrombotic risk minimization for Diane-35 and generics. Pharmacoepidemiology and drug safety, 2017, Volume: 26, Issue:11 Topics: Acne Vulgaris; Adolescent; Adult; Aged; Androgen Antagonists; Cohort Studies; Cyproterone Acetate; Databases, Factual; Drug Combinations; Drug Utilization; Drugs, Generic; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperandrogenism; Menstruation Disturbances; Middle Aged; Netherlands; Retrospective Studies; Risk Reduction Behavior; Thrombosis; Young Adult	2017
European Commission orders France to lift ban on acne pill. BMJ (Clinical research ed.), 2013, Aug-05, Volume: 347 Topics: Acne Vulgaris; Androgen Antagonists; Contraceptives, Oral; Cyproterone Acetate; Drug Administration Schedule; Drug Combinations; Drug Labeling; Ethinyl Estradiol; European Union; Female; France; Humans; Pulmonary Embolism; Safety-Based Drug Withdrawals; Thrombosis	2013
[Thrombosis and embolism during Diane-35 use: analysis of reports made to the Netherlands Pharmacovigilance Centre Lareb]. Nederlands tijdschrift voor geneeskunde, 2014, Volume: 158 Topics: Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Embolism; Ethinyl Estradiol; Female; Humans; Male; Netherlands; Pharmacovigilance; Risk Factors; Thrombosis	2014
[Pill matters: targeted research into side effects necessary]. Nederlands tijdschrift voor geneeskunde, 2014, Volume: 158 Topics: Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Embolism; Ethinyl Estradiol; Female; Humans; Male; Pharmacovigilance; Thrombosis	2014
Reflections after the Diane affair. Journal of thrombosis and haemostasis : JTH, 2014, Volume: 12, Issue:9 Topics: Adult; Adverse Drug Reaction Reporting Systems; Cyproterone Acetate; Drug Combinations; Drug Industry; Ethinyl Estradiol; Female; France; Humans; Pharmacovigilance; Thrombosis	2014
Increased thrombin-activatable fibrinolysis inhibitor antigen levels as a clue for prothrombotic state in polycystic ovary syndrome. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2008, Volume: 24, Issue:9 Topics: Adult; Antigens; Carboxypeptidase B2; Cardiovascular Diseases; Case-Control Studies; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Models, Biological; Polycystic Ovary Syndrome; Risk Factors; Thrombosis; Up-Regulation; Young Adult	2008
Thrombosis and antibodies to cyproterone acetate. Lancet (London, England), 1991, Jan-12, Volume: 337, Issue:8733 Topics: Androgen Antagonists; Antibodies; Cyproterone; Cyproterone Acetate; Humans; Thrombosis	1991
Deep venous thrombosis and antibodies to cyproterone acetate. Lancet (London, England), 1990, Aug-25, Volume: 336, Issue:8713 Topics: Adult; Androgen Antagonists; Antibodies; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Iliac Vein; Thrombosis	1990
[Effects of an anti-androgen combination preparation on the hemostatic system]. Fortschritte der Medizin, 1987, Jan-30, Volume: 105, Issue:3 Topics: Adolescent; Adult; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Risk; Thrombosis	1987